Carisma Therapeutics, Inc.
CARM
$0.06
$0.019.62%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 557.51% | -5.48% | 47.46% | -38.84% | -13.80% |
| Total Depreciation and Amortization | -- | -100.00% | -1.20% | -9.23% | 189.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.47% | 251.23% | 146.95% | -70.79% | -44.63% |
| Change in Net Operating Assets | -2,978.28% | 52.89% | -136.98% | 355.57% | 65.06% |
| Cash from Operations | 132.32% | 41.35% | -20.53% | 35.85% | 19.23% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -68.89% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -68.89% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -5.70% | -1.19% | -930.99% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | 6,350.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -0.97% | -34.49% | -731.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.55% | 43.54% | -13.34% | 33.45% | 16.54% |